Do you want to read an article? Please log in or register.
Everolimus is effective in the pancreas, but also in the stomach, intestine and lungs
Breast CancerGastrointestinal CancerGenitourinary Cancer
Related content
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: A model-based cost-effectiveness analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Diaz M, Garcia M, Vidal C, Santiago A, Gnutti G, Gómez D, Trapero-Bertran M, Fu M, Lung Cancer Prevention LUCAPREV research group.
doi: 10.1016/j.lungcan.2021.06.027
Lung, Respiratory and Thoracic Cancer
Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study
Lung Cancer.
Tomonaga Y, Ten Haaf K, Frauenfelder T, Kohler M, Kouyos RD, Shilaih M, Lorez M, de Koning HJ, Schwenkglenks M, Puhan MA
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: A model-based cost-effectiveness analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Diaz M, Garcia M, Vidal C, Santiago A, Gnutti G, Gómez D, Trapero-Bertran M, Fu M, Lung Cancer Prevention LUCAPREV research group.
doi: 10.1016/j.lungcan.2021.06.027
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France
Lung Cancer.
Chouaid C, Bensimon L, Clay E, Millier A, Levy-Bachelot L, Huang M, Levy P
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
JAMA Oncol.
Berner F, Bomze D, Diem S, Ali OH, Fässler M, Ring S, Niederer R, Ackermann CJ, Baumgaertner P, Pikor N, Cruz CG, van de Veen W, Akdis M, Nikolaev S, Läubli H, Zippelius A, Hartmann F, Cheng HW, Hönger G, Recher M, Goldman J, Cozzio A, Früh M, Neefjes J, Driessen C, Ludewig B, Hegazy AN, Jochum W, Speiser DE, Flatz L
doi: 10.1001/jamaoncol.2019.0402
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers: A Phase 1/2 Single-Group Open-Label Trial
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
JAMA Oncol.
Yu HA, Schoenfeld AJ, Makhnin A, Kim R, Rizvi H, Tsui D, Falcon C, Houck-Loomis B, Meng F, Yang JL, Tobi Y, Heller G, Ahn L, Hayes SA, Young RJ, Arcila ME, Berger M, Chaft JE, Ladanyi M, Riely GJ, Kris MG
doi: 10.1001/jamaoncol.2020.1260.
Lung, Respiratory and Thoracic Cancer
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Oncol.
Pavel ME, Singh S, Strosberg JR, Bubuteishvili-Pacaud L, Degtyarev E, Neary MP, Carnaghi C, Tomasek J, Wolin E, Raderer M, Lahner H, Valle JW, Pommier R, Van Cutsem E, Tesselaar MET, Fave GD, Buzzoni R, Hunger M, Eriksson J, Cella D, Ricci JF, Fazio N, Kulke MH, Yao JC
doi: 10.1016/
Lung, Respiratory and Thoracic Cancer
Cost-Effectiveness Analysis of Afatinib versus Gefitinib for First-Line Treatment of Advanced EGFR-Mutated Advanced Non-Small Cell Lung Cancers
J Thorac Oncol.
Chouaid C, Luciani L, LeLay K, Do P, Bennouna J, Perol M, Moro-Sibilot D, Vergnenègre A, de Pouvourville G
doi: 10.1016/j.jtho.2017.07.013.
RECOMMENDED
Breast Cancer
Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators: A Phase 2 Randomized Clinical Trial
★ 1
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
JAMA Oncol
Fan Y, Sun T, Shao Z, Zhang Q, Ouyang Q, Tong Z, Wang S, Luo Y, Teng Y, Wang X, Wang S, Liu Q, Feng J, Shen K, Song Y, Wang J, Ma F, Li Q, Zhang P, Xu B
doi: 10.1001/jamaoncol.2021.3428